Phospholamban: a prominent regulator of myocardial contractility

Circulation Research
K L Koss, E G Kranias

Abstract

Our understanding of the role of phospholamban in cardiac physiology has evolved over the past two decades to the point where this protein is now understood to be a critical repressor of myocardial contractility. Phospholamban, through its inhibitory effects on the affinity of the cardiac sarcoplasmic reticulum Ca2+ pump for Ca2+, represses both the rates of relaxation and contraction in the mammalian heart. These inhibitory effects can be relieved through (1) phospholamban phosphorylation, (2) down-regulation of phospholamban gene expression, and (3) disruption of the phospholamban-Ca(2+)-ATPase interaction. Thus, genetic approaches and pharmacological interventions, designed to relieve the phospholamban inhibitory action on the cardiac sarcoplasmic reticulum Ca2+ pump and myocardial relaxation, may prove valuable in reversing the effects of several diseases in the mammalian heart. Such interventions could be designed to inhibit the phospholamban phosphatase, stabilize the phosphorylated state of phospholamban, interrupt the phospholamban-Ca(2+)-ATPase interaction, decrease phospholamban transcription, or disrupt phospholamban mRNA stability. Development of such therapeutic strategies to target phospholamban will be an importa...Continue Reading

References

Feb 1, 1988·The Biochemical Journal·J L GarveyR J Solaro
Nov 1, 1987·Basic Research in Cardiology·C Mundiña de WeilenmannA Mattiazzi
Jul 1, 1994·Biophysical Journal·J VossD D Thomas
Jul 1, 1996·The American Journal of Physiology·B M WolskaR J Solaro

❮ Previous
Next ❯

Citations

Jun 11, 2002·Journal of Molecular and Cellular Cardiology·Andrzej M JanczewskiEdward G Lakatta
Mar 30, 2011·Heart and Vessels·Yoshiki UeharaMitsuyuki Shimizu
Oct 6, 2006·Pflügers Archiv : European journal of physiology·Christoph ZiskovenKlara Brixius
Apr 2, 2003·Current Atherosclerosis Reports·Briain D MacNeillRoger J Hajjar
Nov 5, 2003·Current Hypertension Reports·Sara Danzi, Irwin Klein
Jul 12, 2011·The Journal of Physiological Sciences : JPS·Mirsada DervisevikDamjan Susleski
Jan 25, 2003·Cell Calcium·F WuytackL Missiaen
Oct 12, 2000·Cellular Signalling·S ChakrabortiG Shaw
Feb 20, 2002·Trends in Cardiovascular Medicine·Dirk Hagemann, Rui-Ping Xiao
Jul 4, 2002·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Holly A ShielsAnthony P Farrell
Oct 24, 2012·Nature Reviews. Cardiology·Changwon KhoRoger J Hajjar
Aug 22, 2000·European Journal of Biochemistry·D H MacLennan
Sep 11, 2009·The Journal of Biological Chemistry·Sanjaya Kumar SahooDo Han Kim
Mar 3, 2010·The Journal of Biological Chemistry·Richard W TsikaJuan Ji
Feb 11, 2009·Antioxidants & Redox Signaling·Mohammad N Jameel, Jianyi Zhang
May 6, 2009·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Jussi T KoivumäkiMatti Weckström
Dec 22, 1999·Annals of the New York Academy of Sciences·G ChuE G Kranias
Dec 22, 1999·Annals of the New York Academy of Sciences·E LoukianovM Periasamy
Dec 22, 1999·Annals of the New York Academy of Sciences·R G Johnson
Apr 11, 2008·American Journal of Physiology. Cell Physiology·Honglan WangMark T Ziolo
Jun 21, 2008·Circulation Research·Leif Erik VingeWalter J Koch
Oct 15, 2011·Circulation Research·Shikha MishraJoan Heller Brown
Feb 28, 2002·Circulation·Federica del MonteRoger J Hajjar
Apr 26, 2011·Reproductive Biology and Endocrinology : RB&E·Altemar S PaigelIvanita Stefanon
Jan 12, 2013·PloS One·Rogerio Faustino RibeiroIvanita Stefanon
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·S EtzionJ Leor
Nov 16, 2004·The Japanese Journal of Physiology·M Takaki
Sep 1, 2000·Lancet·I Klein, K Ojamaa
Oct 12, 2001·European Journal of Heart Failure·M Scheuermann-FreestoneR Willenbrock
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M I MiyamotoR J Hajjar
Jan 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chikashi ToyoshimaDavid H MacLennan
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·R J HajjarA Rosenzweig
Jun 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michio AsahiDavid H MacLennan
Apr 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michio AsahiDavid H MacLennan
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yan PanAndrew Emili
Jun 4, 2014·The Journal of Clinical Investigation·Satoshi OkumuraYoshihiro Ishikawa
May 13, 2006·Journal of Bioenergetics and Biomembranes·Davide GianniRoger J Hajjar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.